Target intelligence / Profile preview

Cell surface proteins and lipids

Molecular classification
Receptor, Ion channel, Transporter, Enzyme, Structural protein, Antigen, Phospholipid, Glycolipid, Sphingolipid, Sterol
01

Overview

Cell surface proteins and lipids collectively refer to the diverse set of proteins and lipid molecules found on the external surface of the cell membrane. Proteins include receptors, ion channels, transporters, enzymes, antigens, and structural proteins; they mediate signal transduction, substance transport, cell–cell interactions, antigen presentation, and serve as drug targets.[5][1][2] Lipids include phospholipids, glycolipids, sphingolipids, and sterols (such as cholesterol); these provide membrane structure, compartmentalization, cellular recognition, and signaling.[9][1][5][3] Both classes are essential for defining cell identity and function, and their dysregulation is implicated in a broad spectrum of diseases ranging from cancer to infections, cardiovascular, and autoimmune conditions.[4][6][8] This entry should be disaggregated for any rigorous molecular target annotation, as its use is too broad for precise pharmacological or mechanistic analysis.

Other names
cell membrane proteins and lipidsmembrane proteins and lipidssurface antigensmembrane constituents
02

Mechanism of action

Receptor antagonism/agonism; Channel blockade; Enzyme inhibition; Immune targeting/antibody binding; Altering lipid composition/structure; Modulating signal transduction pathways

03

Biological functions

Signal transductionTransportCell-cell communicationCell recognitionImmune responseStructural supportEnergy storage
04

Disease associations

CancerInfectionCardiovascular diseaseAutoimmune diseaseNeurodegenerative diseaseInflammation
05

Safety considerations

Off-target effects due to ubiquitous membrane protein/lipid functionsAutoimmune reactions (cross-reactivity with antigens)Cytotoxicity or cellular dysfunction due to disruption of membrane integrityAltered cellular communication or signaling
06

Interacting drugs

monoclonal antibodies (e.g., trastuzumab targets HER2)

5 more in the full profile.

07

Biomarkers

CD antigens (e.g., CD4, CD19)HER2, EGFRLDL receptor statusGlycolipid or phospholipid alterations in disease statesSurface antigen expression in cancer or infection

Beyond the preview

Go deeper on Cell surface proteins and lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell surface proteins and lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call